カート 0 品物 $0.00
Generic Velpanat
Velpanat
Velpanat is an antiviral combination of sofosbuvir and velpatasvir used to treat chronic hepatitis C virus (HCV) infection across all major genotypes.
セレクト用量: 400/100mg
400/100mg
28tabs
Velpanat $1847.99
$1539.99
$55.00 当たり tab
+ 無料の標準の航空サービス
+ パッケージ配達保険
+ 次の受注は10%の割引を
カートに追加
保存: $0.00
400/100mg
56tabs
Velpanat $3494.39
$2911.99
$52.00 当たり tab
+ 無料の標準の航空サービス
+ パッケージ配達保険
+ 次の受注は10%の割引を
カートに追加
保存: $168.00
ご注文は、安全·安心なパックさ24時間以内に急派される。これはパーセルが(本当出荷項目の映像)のようになります正確にどのようにである。これは、サイズと、通常の民間の手紙(9.4x4.3x0.3インチか24x11x0.7cm)の外観持っており、その内容が開示していない
郵送方法 配信時間 価格  
配信 14-21 日 10$ トラッキング#入手可能 4 日
配信 9-14 日 30$ トラッキング#入手可能 2 日
ワールドワイドシッピング 秘密性と匿名の保証
安全·安心な 控えめ探しパッケージ
24時間以内発送受注 100%成功の配信
口コミ 製品説明
があり瞬間にこの作品のレビューはありませんがあなたが追加して最初にすることができたり、関連製品についてサクセスストーリーページで詳細を読むことができ.
レビューを送信

Common use

Velpanat is prescribed for the treatment of chronic hepatitis C in adults. The combination of sofosbuvir (a nucleotide polymerase inhibitor) and velpatasvir (an NS5A inhibitor) works by blocking the virus’s ability to replicate and spread in the body, leading to viral clearance when taken as directed.

Dosage and direction

Velpanat is taken once daily, with or without food. Tablets should be swallowed whole. Treatment duration is typically 12 weeks but may vary depending on hepatitis C genotype, liver condition, or prior therapy. Follow your healthcare provider’s instructions carefully.

Precautions

Inform your doctor if you have a history of liver failure, hepatitis B infection, kidney disease, or if you take medications for heart rhythm issues. Patients co-infected with HBV and HCV may be at risk of HBV reactivation. Do not stop treatment without consulting your doctor.

Contraindications

Velpanat is contraindicated in individuals with known hypersensitivity to sofosbuvir, velpatasvir, or any tablet components. It should not be used with certain medications that significantly reduce velpatasvir levels.

Possible side effect

Common side effects include headache, fatigue, nausea, and insomnia. Less common but serious effects may include slow heartbeat (especially if taken with amiodarone), liver function changes, or allergic reactions. Seek medical attention for severe or unusual symptoms.

Drug interaction

Velpanat may interact with antacids, proton pump inhibitors, rifampicin, St. John’s Wort, certain anticonvulsants, and HIV medications. Some interactions may reduce effectiveness. Always inform your healthcare provider of all medications and supplements you take.

Missed dose

If you miss a dose, take it as soon as you remember. If it is almost time for the next dose, skip the missed one. Do not double the dose.

Overdose

Overdose may cause severe headache, fatigue, nausea, or general discomfort. Seek medical attention immediately if an overdose is suspected.

Storage

Store Velpanat at room temperature, away from moisture, heat, and direct sunlight. Keep it in its original bottle and out of reach of children.

Disclaimer

We provide only general information about medications which does not cover all directions, possible drug integrations, or precautions. Information at the site cannot be used for self-treatment and self-diagnosis. Any specific instructions for a particular patient should be agreed with your health care adviser or doctor in charge of the case. We disclaim reliability of this information and mistakes it could contain. We are not responsible for any direct, indirect, special or other indirect damage as a result of any use of the information on this site and also for consequences of self-treatment.

口コミ
Wolfgang Müller, Freiburg, Germany
拝啓、非常に短納期ありがとうございました。私は非常に嬉しく思いますし、また、将来的にあなたからオーダーします。
続きを読む»
ピーター・ハン
商品の質とサービスにとても満足しています。オンラインチャットは質問があるときにとても役立ちました。私の注文はサイトに表示された通りに到着しました。言うことなしです。
続きを読む»
ニュース
Hundreds of thousands of women get morning-after pill via free pharmacy service
Since October, the morning-after pill has been made available free-of-charge at high street pharmacies under a new scheme in England.
Badenoch says PM must rule out tax rises to fund social care reform
In a letter to the PM, the Conservative leader offers to work with him on adult social care reform.
Burnham to address social care, youth unemployment and devolution
A No 10 source says it is an attempt by the prime minister to show he is "hitting the ground running".
First person gets new experimental vaccine for Ebola
Ed Hunt, 37 and from the UK, voluteered after seeing news reports of the deadly Ebola outbreak in DR Congo.
配送オプション